|
With funding from the European Commission, IPM hosted a one-day consultation, Understanding Microbicide Introduction in Africa and India, on August 13 in Toronto, Canada. The consultation brought together leading experts in the reproductive health, microbicide and broader HIV/AIDS fields. Presentation topics included a review of experiences from the introduction of reproductive health products and factors impacting microbicide introduction in Nigeria, Rwanda, South Africa, Tanzania, Zambia and India. The results of studies modeling the impact of microbicides and HIV vaccines in developing countries were presented and current plans for microbicide introduction were discussed. Participants also provided views on the design of planned studies IPM will commission to model the impact of different policy decisions on microbicide introduction in select developing countries.
 |
Introduction of Contraceptive Technologies: Lessons for Microbicide Access
Dr. George F. Brown |
|
Planning for the Introduction of HPV Vaccines In Developing Countries: Challenges, Opportunities and Lessons to Learn
Dr. Christopher J. Elias, President, Program for Appropriate Technology in Health (PATH) |
|
Planning for the Introduction of Microbicides
Dr. Timothy M. M. Farley, Coordinator, Control of Sexually Transmitted Infections, Department of Reproductive Health and Research, World Health Organization |
|
Experiences and Lessons from Modeling HIV Vaccines
Mr. John Stover, President, Futures Institute |
|
What Do We Currently Know About Modeling Microbicide Impact?
Dr. Charlotte Watts, Head, Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine |
|
Introducing a Microbicide: Factors Impacting Country Adoption in India, Nigeria, Rwanda and Tanzania
Dr. Bruce Mackay, Director of Programmes, Constella Futures (Europe) |
|
Introducing a Microbicide: Factors Impacting Country Adoption in South Africa and Zambia
Dr. Saul Johnson, Managing Director, Health and Development Africa |
|
